You said -- " The BOOOM potential for Cytodyn is not via the Orphan pathway.
https://investorshangout.com/post/view?id=6817147
___
This is a excerpt copied, of what I said----
" 6-7K total different RD's.
Tumors. Viruses. Bacteria. Etc, etc....
If only even 10% express high CCR5, then BOOOM !!...for those indications
___
I said indications ---- as in for patients. But i'll add to it re-postings on why RD's IS, a potential "booom", for indications, AND, Cytodyn, since you were....correcting, me:
More than half of the 1 in 10 Americans affected by rare diseases are children, and the preponderant majority (95%) of the over 7,000 rare diseases do not have an available therapy.
https://investorshangout.com/post/view?id=6807050
___
We know Mr. Hoffman said will be seeking Orphan Drug Status.
FDA Rare Disease Innovation Hub:
https://www.fda.gov/industry/medical-products...vation-hub
Cytodyn is very possibly positioning LL + ICI for Glioblastoma, Pancreatic & Sarcoma, to start the process of a qualifying Rare Disease treatment and opening the window to all Rare Diseases expressing CCR5.
As a brainstorm after the FcRn abstract, i said LL/LL-PLS could become the cornerstone to a new medical hub.
https://investorshangout.com/post/view?id=6807050
___
Accelerated Approval can also have a rolling BLA review attached to it's Confirmary Trial period. Leading to full, unrestricted approval.
https://investorshangout.com/post/view?id=6807072
___
Most FDA approvals are for RD's...look it up
You sarcastically say, RD's is not a boom pathway for Cytodyn .....I seriously disagree & again say it's a BOOOM!! for the indications. The Social imaging alone, would be phenomenal for a Cytodyn --- Cytodyn/partnership.....
https://investorshangout.com/post/view?id=6817147
___
This is a excerpt copied, of what I said----
" 6-7K total different RD's.
Tumors. Viruses. Bacteria. Etc, etc....
If only even 10% express high CCR5, then BOOOM !!...for those indications
___
I said indications ---- as in for patients. But i'll add to it re-postings on why RD's IS, a potential "booom", for indications, AND, Cytodyn, since you were....correcting, me:
More than half of the 1 in 10 Americans affected by rare diseases are children, and the preponderant majority (95%) of the over 7,000 rare diseases do not have an available therapy.
https://investorshangout.com/post/view?id=6807050
___
We know Mr. Hoffman said will be seeking Orphan Drug Status.
FDA Rare Disease Innovation Hub:
https://www.fda.gov/industry/medical-products...vation-hub
Cytodyn is very possibly positioning LL + ICI for Glioblastoma, Pancreatic & Sarcoma, to start the process of a qualifying Rare Disease treatment and opening the window to all Rare Diseases expressing CCR5.
As a brainstorm after the FcRn abstract, i said LL/LL-PLS could become the cornerstone to a new medical hub.
https://investorshangout.com/post/view?id=6807050
___
Accelerated Approval can also have a rolling BLA review attached to it's Confirmary Trial period. Leading to full, unrestricted approval.
https://investorshangout.com/post/view?id=6807072
___
Most FDA approvals are for RD's...look it up
You sarcastically say, RD's is not a boom pathway for Cytodyn .....I seriously disagree & again say it's a BOOOM!! for the indications. The Social imaging alone, would be phenomenal for a Cytodyn --- Cytodyn/partnership.....
3
